MedTrace Logo

Biomarker Guided Intervention for Prevention of Acute Kidney Injury

NCT02500394 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2017-05-05

No results posted yet for this study

Summary

This study evaluates the impact of a biomarked guided intervention on the development of acute kidney injury in high risk surgical patients. Eligible patients are screened for marker of tubular stress in the urine; if patient specific results are above a pre-defined cutoff they are randomized into a standard care group or an interventional group in which patients receive intensified volume therapy.

Conditions

Interventions

PROCEDURE

Ionosteril

biomarker guided volume substitution with Ionosteril

Sponsors & Collaborators

  • University Hospital Regensburg

    lead OTHER

Principal Investigators

  • Tobias Bergler, MD · UKR-Department of Nephrology

  • Ivan Göcze, MD · UKR-Department of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-12-31
Completion
2017-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02500394 on ClinicalTrials.gov